Risks of Major Adverse Kidney Events in Non-Hispanic Black Patients with Diabetes or Hypertension: A real-world cohort study

Related

• Kidney Medicine·4 Oct 2026

  Neighborhood disadvantage links to dementia in kidney failure

  

• The American Journal of Cardiology·8 Oct 2026

  Drug class linked to fewer deaths or complications in kidney disease

  

• Clinical Journal of the American Society of Nephrology·4 Oct 2026

  SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes

• Diabetes, Obesity & Metabolism·4 Oct 2026

  GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk